SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending downwards as community members discuss leveraged liquidations, ETF outflows, and technical breakdowns, with some speculating on further drops. Concerns about whales dumping and stocks outperforming add to the bearish sentiment. Despite some dip buying, overall sentiment suggests caution amid discussions of potential support levels and market manipulation.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA ($NVDA) is trending as investors await earnings, with anticipation high for another strong report driven by AI and data center demand; however, some community members are concerned about already high expectations and potential for a sell-off, regardless of the results. Discussions also include the stock's influence on broader market trends and potential shifts in the AI sector.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

NUVB is trending as chatter increases about its potential value compared to competitors, particularly NUVL, with discussions focusing on Ibtrozi's market performance and upcoming catalysts. Community members are closely watching for developments related to EU partnerships and progress on the IDH1 program. Bullish sentiment is building as investors anticipate positive updates and potential for a short squeeze, viewing the current price as undervalued given the company's prospects in the oncology space.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal ($PYPL) is trending downwards, with community sentiment turning bearish after the CEO's cautious outlook at a recent conference, overshadowing positive aspects like dividend payments and buybacks. Discussions revolve around the stock's continued decline despite broader market gains and a seemingly attractive valuation. Frustrated shareholders are questioning leadership and the company's strategic direction amidst concerns about branded checkout performance.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as investors discuss the potential impact of critical mineral supply chains and geopolitical tensions on the deep-sea mining company. Community members are focused on potential government partnerships, policy changes, and recent Wedbush analyst target, alongside speculation of Saudi investment. Some traders remain cautious, citing the speculative nature of the stock and the long-term timeline for potential revenue.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as traders discuss its correlation to Bitcoin's volatile price action and potential downside risks. Community members are debating the impact of MicroStrategy's leveraged Bitcoin holdings and the possibility of further price drops, while others anticipate a rebound. The stock's relationship with Bitcoin and broader market sentiment appears to be a key focus.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is trending due to news of a significant investment by Berkshire Hathaway, seen as validation of its AI leadership. The community is discussing the potential impact of this investment and Google's overall position in the tech sector, while also noting upcoming catalysts such as Gemini 3 and Waymo expansion.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is trending amid mixed reactions to Q3 earnings, which beat EPS estimates but missed on revenue, sparking debate about its near-term performance. Community discussions revolve around the company's turnaround efforts, including cost-cutting measures and AI integration, with some questioning its competitive position against discount retailers and the impact of consumer spending trends.  The stock's potential for recovery and long-term value, especially with its dividend, is also a key talking point.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

CRCL is trending downward, driven by concerns surrounding the expiration of the IPO lockup period and insider selling, despite recent earnings. Community members are discussing potential entry points as the stock approaches its IPO price, with some speculating about a short squeeze. The broader crypto market's volatility and its impact on CRCL are also key talking points.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as investors discuss the recent price decline despite previously rallying after earnings, with many focusing on the impact of warrant distribution and related options activity. The community is debating whether this dip represents a buying opportunity or signals deeper concerns about the stock's meme status and potential manipulation. Some are drawing comparisons to other companies, like Carvana and Palantir, while others point to the broader real estate market and interest rate environment as contributing factors.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CLSD No one will buy this company. If the dissolved company closes due to bankruptcy, the intellectual property will be sold off to highest offer to make payments to creditors.

StockTwits Web

Clearside Biomedical Inc

 No one will buy this company. If the dissolved company closes due to bankruptcy, the intellectual property will be sold off to highest offer to make payments to creditors.

Tom Koli

@2020Stop  
The end issue is that they have like 2.7 million in current liabilities which is basically nothing, the company does not have creditors.

  
The end issue is that they have like 2.7 million in current liabilities which is basically nothing, the company does not have creditors.

None Ofya

@rando321456 Clearside Biomedical, Inc. (CLSD) financial forecasts for 2026 project an average revenue of $3.43 million and an average loss per share (EPS) of $4.78. The company is currently facing financial challenges, including a potential delisting from Nasdaq due to low market value. On August 28, 2025, the company received a notice from Nasdaq for not meeting the minimum market value requirement ($50 million). Clearside has until February 24, 2026, to regain compliance.

 Clearside Biomedical, Inc. (CLSD) financial forecasts for 2026 project an average revenue of $3.43 million and an average loss per share (EPS) of $4.78. The company is currently facing financial challenges, including a potential delisting from Nasdaq due to low market value. On August 28, 2025, the company received a notice from Nasdaq for not meeting the minimum market value requirement ($50 million). Clearside has until February 24, 2026, to regain compliance.

@2020Stop  
For Nasdaq the consensus is that they are currently in compliance as they switched from the global to capital market.

  
For Nasdaq the consensus is that they are currently in compliance as they switched from the global to capital market.

@2020Stop looking forward to seeing you eat your words in the next 1-2 months when CLSD gets acquired. 

Everyone said the same about $ADVM, and we are in a much better position financially than Adverum, which will result in us getting a much better deal.  

All of big Pharma is looking to get into the retina space, as well as major ophthalmology companies, which still do not have any AMD treatments available. This is going to be the fastest growing market segment in biotech over the next 3 to 5 years.  

The SCS injector IP alone is worth 2-3x current valuation, in addition to drug pipeline which would fit nicely in a massive revenue driven retina space.  

The reward at investing at these levels far outweighs the risk.  I’m grateful for the dip and have been adding shares over the past two months $CLSD

StockTwits for iOS

Adverum Biotechnologies Inc

 looking forward to seeing you eat your words in the next 1-2 months when CLSD gets acquired. 

Everyone said the same about 

, and we are in a much better position financially than Adverum, which will result in us getting a much better deal.  

All of big Pharma is looking to get into the retina space, as well as major ophthalmology companies, which still do not have any AMD treatments available. This is going to be the fastest growing market segment in biotech over the next 3 to 5 years.  

The SCS injector IP alone is worth 2-3x current valuation, in addition to drug pipeline which would fit nicely in a massive revenue driven retina space.  

The reward at investing at these levels far outweighs the risk.  I’m grateful for the dip and have been adding shares over the past two months 

Adam Mak

@BaroloBuff In my opinion looking like another failed biotech. Reverse split not good and is usually the death spiral for a company.These bigger companies are just waiting to pick it up for almost nothing. Next big news is Chapter 11...

 In my opinion looking like another failed biotech. Reverse split not good and is usually the death spiral for a company.These bigger companies are just waiting to pick it up for almost nothing. Next big news is Chapter 11...

@2020Stop whatever you say, Shorty. 

Before you make assumptions like this, get your facts straight on the inaccurate information that you posted. ￼

 whatever you say, Shorty. 

Before you make assumptions like this, get your facts straight on the inaccurate information that you posted. ￼

@BaroloBuff one of us is definitely right and we&#39;ll find out who in 3 months..

 one of us is definitely right and we'll find out who in 3 months..